Update your location to show providers, locations, and services closest to you.
Cancer Specialist (Oncologist), Urologist
My name is Padraic O’Malley, MSc, MD, FRCSC, and I am a clinical assistant professor in the University of Florida Department of Urology and chief of urologic oncology. Following medical school at Saba University School of Medicine, I completed my urology residency at the University of Toronto in Toronto, Canada, where I was awarded the Undergraduate Teaching Award. I completed my urologic oncology fellowship at Weill-Cornell Medical College in New York, New York, where I was awarded the Ferdinand C. Valentine Fellowship Award. I joined UF Health in 2018 and have since been awarded a UF College of Medicine Exemplary Teacher award as well as the Department of Urology Rising Star Award.
Currently, I am a board member of the Florida Urological Society and Southeastern section of the American Urological Association. I am also a member of the American Urological Association, the Canadian Urological Association, the Endourological Society and the Society of Urologic Oncology, in addition to being an international member of the European Association of Urology. Along with seeing patients and teaching, I have contributed as an author to a number of urology-based publications, chapters and abstracts.
My clinical interests revolve around urologic oncology, multidisciplinary care and robotic surgical techniques. I perform complex robotic surgery with a special interest in bladder and kidney cancer. This includes treating IVC thrombus, performing robotic and open tumor thrombectomies, and robotic and open retroperitoneal lymph node dissection. I serve as a sub-investigator on a number of clinical trials for bladder, kidney and prostate cancer. My research interests examine the tumor microenvironment in bladder and kidney cancer, the use of novel nanoparticle and artificial intelligence-powered analysis of exosome-based, multi-fluid multi-omics in bladder cancer, and the use of surgery in advanced kidney cancer.
During my free time, I enjoy spending time with my wife and children, traveling, playing and watching sports (rugby, in particular), and cooking with my smoker.
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to…
The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will result in a non-inferior event-free survival (EFS) compared to standard treatment with…
Please note: Some physicians and practices might not accept a specific insurance plan. Our list is also subject to change, and sometimes that change is not yet reflected in this list. Please contact the practice to confirm that your insurance is accepted. A representative will be happy to assist you.
See all insurancesMarch is National Kidney Cancer Awareness Month, so it’s a great time to put the spotlight on these amazing organs that act as a pair of janitors in many ways.…
From kayaking through the Everglades to backpacking around the Grand Canyon, 61-year-old Bob Wisneski enjoys adventuring around the country and embracing the…
